β-blockers improve survival of patients with chronic obstructive pulmonary disease after coronary artery bypass grafting

Annals of Thoracic Surgery

Volumn 95, Issue 2, 2013, Pages 525-531

  Angeloni, Emiliano ^a   Melina, Giovanni ^a   Roscitano, Antonino ^a   Refice, Simone ^a   Capuano, Fabio ^a   Lechiancole, Andrea ^a   Comito, Cosimo ^a   Benedetto, Umberto ^a   Sinatra, Riccardo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; METOPROLOL; NEBIVOLOL; PREDNISOLONE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVIVAL RATE;

EID: 84872820965     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.07.080     Document Type: Article

References (34)

1. K.F. Rabe, S. Hurd, A. Anzueto Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
2. C.J. Murray, A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 349 1997 1498 1504
3. D.D. Sin, S.F. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519
4. F.H. Rutten, M.J. Cramer, D.E. Grobbee Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease Eur Heart J 26 2005 1887 1894
5. F.H. Rutten, N.P.A. Zuithoff, E. Hak, D.E. Grobbee, A.W. Hoes Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease Arch Intern Med 170 2010 880 887
6. B. Medalion, M.G. Katz, A.J. Cohen, E. Hauptman, L. Sasson, A. Schachner Long-term beneficial effect of coronary artery bypass grafting in patients with COPD Chest 125 2004 56 62
7. B.J. Leavitt, C.S. Ross, B. Spence Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery Circulation 114 1 Suppl 2006 I-430 I-434
8. R.A. Clough, B.J. Leavitt, J.R. Morton, Plume et al. The effect of comorbid illness on mortality outcomes in cardiac surgery Arch Surg 137 2002 428 432
9. E.L. Hannan, C. Wu, E.V. Bennett Risk stratification of in-hospital mortality for coronary artery bypass graft surgery J Am Coll Cardiol 47 2006 661 668
10. S.C. Smith Jr, J. Allen, S.N. Blair AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2006 2363 2372
11. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
12. S.S. Gottlieb, R.J. McCarter, R.A. Vogel Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N Engl J Med 339 1998 489 497
13. M. Packer, M.B. Fowler, E.B. Roecker Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 106 2002 2194 2199
14. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
15. K.B. Filion, L. Pilote, E. Rahme, M.J. Eisenberg Perioperative use of cardiac medical therapy among patients undergoing coronary artery bypass graft surgery: a systematic review Am Heart J 154 2007 407 414
16. A. Wallace, B. Layug, I. Tateo et al. Prophylactic atenolol reduces postoperative myocardial ischemia McSPI Research Group Anesthesiology 88 1998 7 17
17. Heart Failure Society of America J. Lindenfeld, N.M. Albert et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline J Card Fail 16 2010 e1 e194
18. H.R. Phillips, C.M. O'Connor, J. Rogers Revascularization for heart failure Am Heart J 153 4 Suppl 2007 65 73
19. L.D. Hillis, P.K. Smith, J.L. Anderson 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 124 2011 2610 2642
20. Y. Ling, W. Saleem, C.D. Shee Concomitant use of beta-blockers and beta2-agonists Eur Respir J 31 2008 905 906
21. B.A. Olenchock, G.G. Fonarow, W. Pan, A. Hernandez, C.P. Cannon Get With The Guidelines Steering Committee Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes Am J Cardiol 103 2009 295 300
22. M. Egred, S. Shaw, B. Mohammad, P. Waitt, E. Rodrigues Under-use of betablockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease Q J Med 98 2005 493 497
23. S. Andreas, S.D. Anker, P.D. Scanlon, V.K. Somers Neurohumoral activation as a link to systemic manifestations of chronic lung disease Chest 128 2005 3618 3624
24. S.R. Salpeter, T.M. Ormiston, E.E. Salpeter, P.J. Poole, C.J. Cates Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis Respir Med 97 2003 1094 1101
25. Y.R. van Gestel, S.E. Hoeks, D.D. Sin Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD Int J Chron Obstruct Pulmon Dis 4 2009 177 183
26. S.R. Salpeter, T.M. Ormiston, E.E. Salpeter Cardioselective beta-blockers for chronic obstructive pulmonary disease Cochrane Database Syst Rev 4 2005 CD003566
27. V. Snow, S. Lascher, C. Pilson The evidence base for management of acute exacerbation of COPD Clinical Practice Guideline, Part 1 Chest 119 2001 1185 1189
28. British Thoracic Society Standards of Care Committee NIPPV non-invasive ventilation in acute respiratory failure Thorax 57 2005 192 211
29. E.H. Blackstone Comparing apples and oranges J Thorac Cardiovasc Surg 123 2002 8 15
30. G.B. Mancini, M. Etminan, B. Zhang, L.E. Levesque, J.M. FitzGerald, J.M. Brophy Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease J Am Coll Cardiol 47 2006 2554 2560
31. R. Lin, H. Peng, L.P. Nguyen Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of "beta- blockers" in a murine asthma model Pulm Pharmacol Ther 21 2008 115 124
32. L.P. Nguyen, O. Omoluabi, S. Parra Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model Am J Respir Cell Mol Biol 38 2008 256 262
33. Z. Callaerts-Vegh, K.L. Evans, N. Dudekula Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma Proc Natl Acad Sci U S A 101 2004 4948 4953
34. K. Fox, J.S. Borer, A.J. Camm Resting heart rate in cardiovascular disease J Am Coll Cardiol 50 2007 823 830